HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The neuroprotective effect of pretreatment with carbon dots from Crinis Carbonisatus (carbonized human hair) against cerebral ischemia reperfusion injury.

AbstractBACKGROUND:
Cerebral infarction and cerebral hemorrhage, also known as "stroke", is one of the leading cause of death. At present, there is no real specific medicine for stroke. Crinis Carbonisatus (named Xue-yu-tan in Chinese), produced from carbonized hair of healthy human, and has been widely applied to relieve pain and treat epilepsy, stroke and other diseases in China for thousands of years.
RESULTS:
In this work, a new species of carbon dots derived from Crinis Carbonisatus (CrCi-CDs) were separated and identified. And the neuroprotective effect of carbon dots from CrCi were evaluated using the middle cerebral artery occlusion (MCAO) model. Neurological deficit score and infarction volume was assessed, evans blue content of ischemic hemispheres was measured, the concentrations of inflammatory factors, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) in the cortex were measured, and the levels of neurotransmitters in the brain were determined. Preconditioning of CrCi-CDs significantly reduced ischemic lesion volume and blood-brain-barrier (BBB) permeability, improved neurologic deficits, decreased the level of TNF-α and IL-6 in MCAO rats, inhibited excitatory neurotransmitters aspartate (Asp) and glutamate (Glu), and increased the level of 5-hydroxytryptamine (5-HT). The RNA-Sequencing results reveal that further potential mechanisms behind the activities may be related to the anti-inflammation effects and inhibition of neuroexcitatory toxicity.
CONCLUSION:
CrCi-CDs performs neuroprotective effect on cerebral ischemia and reperfusion injury, and the mechanisms may correlate with its anti-inflammatory action, which suggested that CrCi-CDs have potential value in clinical therapy on the acute apoplexy cases in combination with thrombolytic drugs.
AuthorsYue Zhang, Suna Wang, Fang Lu, Meiling Zhang, Hui Kong, Jinjun Cheng, Juan Luo, Yan Zhao, Huihua Qu
JournalJournal of nanobiotechnology (J Nanobiotechnology) Vol. 19 Issue 1 Pg. 257 (Aug 28 2021) ISSN: 1477-3155 [Electronic] England
PMID34454522 (Publication Type: Journal Article)
Copyright© 2021. The Author(s).
Chemical References
  • Interleukin-6
  • Neuroprotective Agents
  • Tumor Necrosis Factor-alpha
  • Carbon
Topics
  • Animals
  • Blood-Brain Barrier
  • Brain
  • Brain Ischemia (pathology)
  • Carbon (pharmacology)
  • Disease Models, Animal
  • Humans
  • Infarction, Middle Cerebral Artery (drug therapy)
  • Inflammation
  • Interleukin-6
  • Male
  • Mice
  • Neuroglia (pathology)
  • Neuroprotective Agents (pharmacology)
  • RAW 264.7 Cells
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (drug therapy, pathology)
  • Stroke (drug therapy)
  • Transcriptome
  • Tumor Necrosis Factor-alpha

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: